Getinge beats Q3 profit estimates as pricing and product mix lift margins

Getinge beats Q3 profit estimates as pricing and product mix lift margins
Getinge beats Q3 profit

After spending the past year offsetting pressure from higher U.S. import tariffs, Getinge posts third-quarter core earnings above market expectations. The Swedish medical equipment maker also extends its run of order growth and maintains its 2026 organic sales forecast of 3% to 5%.

Highlights

  • Getinge's adjusted EBITA rose 18% to 1.28 billion Swedish crowns in Q3, surpassing the 1.19 billion crown analyst estimate due to pricing and product mix.
  • Third-quarter EBITA margin gained from 45 million crowns in tariff refunds, including a $36 million U.S. tariff refund, and about 36 million crowns in positive currency effects.
  • Quarterly orders grew 2.6% organically for an eleventh consecutive quarter, with Getinge maintaining its 2026 organic sales growth outlook of 3% to 5%.

Quarterly earnings and margin drivers

As reported by Reuters, Getinge says adjusted EBITA rises 18% to 1.28 billion Swedish crowns in the third quarter, above the 1.19 billion crowns expected on average in a company-provided analyst poll. The result is supported by a favourable product mix and disciplined pricing as the group continues to manage tariff-related cost pressure.

The company says its third-quarter adjusted EBITA margin benefits from 45 million crowns in tariff refunds and about 36 million crowns from year-on-year currency effects. In July, Getinge receives a refund of tariffs paid under the International Emergency Economic Powers Act, a U.S. federal law, of about $36 million.

Orders growth and 2026 outlook

Getinge, which makes products for surgery, intensive care and sterilisation, says quarterly orders rise 2.6% organically, marking an eleventh straight quarter of growth. The increase is driven by its Acute Care Therapies and Surgical Workflows units.

The group manufactures more than 60% of its products in the U.S. and has been raising prices, cutting costs and adjusting its supply chain to counter higher import tariffs. Getinge, whose products include ventilators and operating room equipment, confirms its forecast for organic sales growth of 3% to 5% for 2026, compared with 4.9% last year.

U.S. toy prices surging ahead of the holiday season was a focus of our earlier coverage, as import duties and energy- and shipping-related costs pushed shelf prices higher than many other consumer categories. We noted that even after some tariff rollbacks, pricing and margins can remain under pressure because inventory was priced under earlier, higher duties and because fuel, commodity, and logistics costs can stay elevated for multiple quarters.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.